NCI vs TSLA
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
Despite a strong Piotroski F-Score of 7/9 and extreme valuation discounts (Graham Number $3.39 vs Price $0.51), NCI exhibits the classic characteristics of a value trap. The company is experiencing a catastrophic price collapse, with a 91.8% decline in the last month and a 98.9% loss over five years. While earnings are growing and ROE is positive, the 24% YoY revenue contraction and total lack of technical momentum suggest a fundamental breakdown in market confidence that outweighs the deterministic value metrics.
Tesla's deterministic health is stable with a Piotroski F-Score of 4/9, but its valuation is fundamentally disconnected from current performance. The Graham Number ($22.85) and Intrinsic Value ($7.42) indicate extreme overvaluation relative to the current price of $343.25. With negative YoY revenue growth (-3.10%) and a collapse in earnings growth (-60.60%), the P/E ratio of 323.82 is unsustainable. Technical trends and insider activity are both strongly bearish, suggesting a significant correction is likely.
Compare Another Pair
Related Comparisons
NCI vs TSLA: Head-to-Head Comparison
This page compares Neo-Concept International Group Holdings Limited (NCI) and Tesla, Inc. (TSLA) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.